Skip to content

Medical-device intelligence

JPK: Mixture, Hematology Quality Control

FDA product code JPK: Mixture, Hematology Quality Control. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JPK
FDA device name
Mixture, Hematology Quality Control
Device class
2
Regulation number
864.8625
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

192 clearance records and 16 recall records in the covered releases, across 58 source company names and 1 product codes. Dated history runs from Aug 4, 1976 to Nov 7, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JPK · Mixture, Hematology Quality Control19216

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

208 matching records
Device / recordCompany in FDA recordSourceSource date
R&D CBC-3D Hematology Control: (1) CBC-3D Normal Pack Hematology Control, REF 3D501, containing 10 x 2.0mL Control N; (2) CBC-3D TRI PACK Hemat…Z-0999-2023 · JPKR & D Systems, Inc.RecallJan 19, 2023FDA classification date
A. MENARINI diagnostics Hb 9210 PREMIER, LEVEL1, LEVEL II, Hemoglobin A1c Controls for hemoglobin A1c Assay, REF 45052, part number 05-01-0926, A…Z-0349-2023 · JPKPrimus Corporation dba Trinity BiotechRecallDec 1, 2022FDA classification date
Trinity Biotech HbA1c (GHb) Contorls Kit, 500uL (Levels I & II), REF 01-04-0020, Part number 05-01-0040B, A1c analysisZ-0350-2023 · JPKPrimus Corporation dba Trinity BiotechRecallDec 1, 2022FDA classification date
RNA MEDICAL, QCHGB HEMOGLOBIN CONTROL, MULTI, REF QC HGB - Product Usage: monitoring the performance of Hemocue Hemoglobin Analyzers. It provides…Z-1249-2021 · JPKMedline Industries IncRecallMar 12, 2021FDA record creation date
BD" Multi-Check CD4 Low Control 2.5 mL IVD - Product Usage: intended as a complete process control for immunophenotyping by flow cytometry.Z-0562-2021 · JPKBecton, Dickinson and Company, BD BiosciencesRecallDec 10, 2020FDA record creation date
XN-L CHECKK160586 · JPKStreck510(k)Dec 22, 2016FDA decision date
XN CHECK BFK160588 · JPKStreck510(k)Dec 22, 2016FDA decision date
XN CHECKK160590 · JPKStreck510(k)Dec 22, 2016FDA decision date
BC-5D Hematology ControlK160606 · JPKR&D Systems, Inc.510(k)Sep 1, 2016FDA decision date
XN CHECK BFK141957 · JPKStreck510(k)Dec 5, 2014FDA decision date
XN CHECKK141964 · JPKStreck510(k)Dec 5, 2014FDA decision date
Boule Con-Diff Tri-Level Multi-Parameter Assayed Hematology Control, used for in vitro diagnostic use as a control to monitor the performance of …Z-1436-2014 · JPKClinical Diagnostic SolutionsRecallApr 9, 2014FDA classification date
R&D 5D RETIC HEMATOLOGY CONTROLK130962 · JPKR&D Systems, Inc.510(k)Jul 24, 2013FDA decision date
Minotrol 16, Model Numbers: 2043748, 2043752, 2043756, Lot Number: MX090(Levels: Low, Normal, and High). Minotrol 16 is a tri-level control inte…Z-0429-2013 · JPKHoriba Instruments, Inc dba Horiba MedicalRecallNov 21, 2012FDA classification date
Boule Con Diff US Tri Pack, 6 Vials. For in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology instrum…Z-0193-2013 · JPKClinical Diagnostic SolutionsRecallNov 5, 2012FDA classification date
Boule Con-Diff Hematology Control 9 vials. For in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology i…Z-0194-2013 · JPKClinical Diagnostic SolutionsRecallNov 5, 2012FDA classification date
Boule Con-Diff Hematology Control For in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology instrument…Z-0189-2013 · JPKClinical Diagnostic SolutionsRecallNov 2, 2012FDA classification date
Boule Con-Diff Hematology Control For in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology instrument…Z-0190-2013 · JPKClinical Diagnostic SolutionsRecallNov 2, 2012FDA classification date
Boule Con-Diff Hematology Control For in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology instrument…Z-0191-2013 · JPKClinical Diagnostic SolutionsRecallNov 2, 2012FDA classification date
XN CHECKK120742 · JPKStreck510(k)Oct 19, 2012FDA decision date
XN CHECK BFK120744 · JPKStreck510(k)Oct 19, 2012FDA decision date
R&D SYSTEMS BODY FLUID-I HEMATOLOGY CONTROLK101578 · JPKR&D Systems, Inc.510(k)Apr 28, 2011FDA decision date
COULTER LIN-X LINEARITY CONTROL, MODEL A81196K100790 · JPKBeckman Coulter, Inc.510(k)Dec 21, 2010FDA decision date
COULTER 4C-EX 300 CELL CONTROLK100607 · JPKBeckman Coulter, Inc.510(k)Nov 18, 2010FDA decision date
LIQUICHEK HEMATOLOGY-16 CONTROL LV, MODEL: 295LVK091303 · JPKBio-Rad Laboratories510(k)Aug 2, 2010FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗